Tuberculosis Clinical Trial Update and the Current Anti-Tuberculosis Drug Portfolio

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|30|3785-3796

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.30, 2013-10, pp. : 3785-3796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tuberculosis

By  

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 105-105

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

By  

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 53-53

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

By  

Current Bioactive Compounds, Vol. 1, Iss. 3, 2005-12 ,pp. : 287-289

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Biology in Anti-Tuberculosis Drug Discovery

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 319-326

Bentham Science Publishers

Access to resources Recommend Favorite

New Anti-Tuberculosis Drugs in Clinical Development: An Overview

By  

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite